Learn More
Log In
Sign Up
21 C.F.R. Part 212 – Current Good Manufacturing Practice for Positron Emission Tomography Drugs | Midpage
Collections
Code of Federal Regulations
Title 21
Chapter I
Subchapter C
Part 212
21 C.F.R. Part 212
Current Good Manufacturing Practice for Positron Emission Tomography Drugs
A
General Provisions
B
Personnel and Resources
C
Quality Assurance
D
Facilities and Equipment
E
Control of Components, Containers, and Closures
F
Production and Process Controls
G
Laboratory Controls
H
Finished Drug Product Controls and Acceptance
I
Packaging and Labeling
J
Distribution
K
Complaint Handling
L
Records